Alice Loo

10.3k citations

19 papers · 2.0k indexed · h-index 16

Oncology top 5%
- Cancer-related Molecular Pathways 4
- Drug Transport and Resistance Mechanisms 2
Genetics top 5%
- Chronic Lymphocytic Leukemia Research 2
Sensory Systems top 5%
Molecular Biology top 10%
- Chemical Synthesis and Analysis 2
Cancer Research top 10%
Physiology
- Alzheimer's disease research and treatments 4
Pulmonary and Respiratory Medicine
- Advanced Breast Cancer Therapies 3
Computational Theory and Mathematics
- Computational Drug Discovery Methods 2
Pharmacology
- Cholinesterase and Neurodegenerative Diseases 2

Co-authors: Christoph Lengauer Frank Stegmeier Susan Wee William R. Sellers Dmitri Wiederschain Yung‐Mae Yao Sauveur-Michel Maira Christine Miller
Cited by: Oncology Genetics Sensory Systems
Journals: Bioorganic & Medicinal Chemistry Letters (4 papers)Oncotarget (3 papers)Cancer Research (3 papers)
Partner nations: United States Switzerland Mexico

In The Last Decade

Alice Loo

19 papers receiving 1.9k citations

Peers

Countries citing papers authored by Alice Loo

Since Specialization

Citations

This map shows the geographic impact of Alice Loo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alice Loo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alice Loo more than expected).

Fields of papers citing papers by Alice Loo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alice Loo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alice Loo. The network helps show where Alice Loo may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Alice Loo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alice Loo Line = papers co-authored together Alice Loo links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work
1	Structural and Biochemical Studies Confirming the Mechanism of Action of Asciminib, an Agent Specifically Targeting the ABL Myristoyl Pocket (STAMP) Blood ·Peter Schuld,Stephan Grzesiek,Luiza Guerra Mendonça,Judith Habazettl,Wolfgang Jahnke,Louise Barys,Sandra W. Cowan‐Jacob,Alice Loo,James M. Termini,Paul W. Manley	2020	8
2	Patient-derived glioblastoma cultures as a tool for small-molecule drug discovery Oncotarget ·Ling F. Ye,Eduard Reznik,Joshua M. Korn,Fallon Lin,Guizhi Yang,陈凌樱,Hui Gao,Alice Loo,Raymond Pagliarini,Tom Mikkelsen,Donald C. Lo,Ana C. deCarvalho,Brent R. Stockwell	2020	15
3	The potent and selective cyclin-dependent kinases 4 and 6 inhibitor ribociclib (LEE011) is a versatile combination partner in preclinical cancer models Oncotarget ·Sunkyu Kim,Ralph Tiedt,Alice Loo,Thomas Horn,Scott Delach,Albert Nadal Zaragoza,Kristy Haas,Barbara Schacher Engstler,D. M. GUEDES,Maria Pinzon-Ortiz,Iain J. Mulford,Michael Acker,Rajiv Chopra,Christopher T. Brain,Emmanuelle di Tomaso,William R. Sellers,Giordano Caponigro	2018	58
4	Antiproliferative Effects of CDK4/6 Inhibition in CDK4 -Amplified Human Liposarcoma In Vitro and In Vivo Molecular Cancer Therapeutics ·公士楠元,Ewa Sicińska,Jeffrey T. Czaplinski,Stephen P. Remillard,Samuel Moss,Yuchuan Wang,Christopher T. Brain,Alice Loo,Eric L. Snyder,George D. Demetri,Sunkyu Kim,Andrew L. Kung,Andrew J. Wagner	2014	98
5	Abstract PR02: LEE011: An orally bioavailable, selective small molecule inhibitor of CDK4/6– Reactivating Rb in cancer. Molecular Cancer Therapeutics ·Sunkyu Kim,Alice Loo,Rajiv Chopra,Giordano Caponigro,Alan Huang,Sadhna Vora,Sudha Parasuraman,美紀佐藤,Nicholas Keen,William R. Sellers,Christopher T. Brain	2013	88
6	Targeting HSF1 sensitizes cancer cells to HSP90 inhibition Oncotarget ·Yaoyu Chen,Jinyun Chen,Alice Loo,Savina Jaeger,Gallayanee Parkatt,Jianjun Yu,Franklin Chung,Joshua M. Korn,David A. Ruddy,Ribo Guo,Margaret E. McLaughlin,Oluyinka Opaleye O,Ping Zhu,Frank Stegmeier,Raymond Pagliarini,Dale Porter,Wenlai Zhou	2013	49
7	2-(N-Benzyl-N-phenylsulfonamido)alkyl amide derivatives as γ-secretase inhibitors Bioorganic & Medicinal Chemistry Letters ·Michael F. Parker,Donna M. Barten,Carl P. Bergstrom,Joanne J. Bronson,Jason A. Corsa,Michael F. Dee,Remco G.W. Nijman,Valerie Guss,Elisabeth Vogelheim,R. P. H. 'Neill,Alice Loo,Robert Mate,Asma Hilyah Al-Aulia,Carl Hartman,Craig Polson,Susan B. Roberts,John E. Macor	2012	2
8	Protein Kinase C Inhibitor Sotrastaurin Selectively Inhibits the Growth of CD79 Mutant Diffuse Large B-Cell Lymphomas Cancer Research ·Tara L. Naylor,Huaping Tang,Boris A. Ratsch,Andreas Enns,Alice Loo,Liqing Chen,Peter Lenz,Nigel J. Waters,W. Schüler,Bernd Dörken,Yung‐Mae Yao,Markus Warmuth,Georg Lenz,Frank Stegmeier	2011	88
9	Maintenance of adenomatous polyposis coli ( APC )-mutant colorectal cancer is dependent on Wnt/β-catenin signaling Proceedings of the National Academy of Sciences ·Alix Scholer‐Dahirel,Michael R. Schlabach,Alice Loo,Gallayanee Parkatt,Ronald A. Meyer,Ribo Guo,Steve Woolfenden,Kristine Yu,Judit Markovits,Xin Qiongzh,Dmitriy Sonkin,Yung‐Mae Yao,Markus Warmuth,William R. Sellers,Robert Schlegel,Frank Stegmeier,Rebecca Mosher,Margaret E. McLaughlin	2011	85
10	The Polycomb Group Protein Bmi-1 Is Essential for the Growth of Multiple Myeloma Cells Cancer Research ·Zainab Jagani,Dmitri Wiederschain,Alice Loo,Dan He,Rebecca Mosher,Paul Fordjour,John E. Monahan,Michael Morrissey,Iustina CONDURECHE,Christoph Lengauer,Markus Warmuth,William R. Sellers,Marion Dorsch	2010	48
11	PI3K Pathway Activation Mediates Resistance to MEK Inhibitors in KRAS Mutant Cancers Cancer Research ·Susan Wee,Zainab Jagani,Kay X. Xiang,Alice Loo,Marion Dorsch,Yung‐Mae Yao,William R. Sellers,Christoph Lengauer,Frank Stegmeier	2009	354
12	Single-vector inducible lentiviral RNAi system for oncology target validation Cell Cycle ·Dmitri Wiederschain,Arianna Oliviero,Lin Chen,Alice Loo,Guizhi Yang,Alan Huang,Yan Chen,Giordano Caponigro,Iustina CONDURECHE,Christoph Lengauer,William R. Sellers,John D. Benson	2009	306
13	PTEN-deficient cancers depend on PIK3CB Proceedings of the National Academy of Sciences ·Susan Wee,Dmitri Wiederschain,Sauveur-Michel Maira,Alice Loo,Christine Miller,Lara Gallardo Valero,Frank Stegmeier,Iustina CONDURECHE,Christoph Lengauer	2008	411
14	Amino-caprolactam derivatives as γ-secretase inhibitors Bioorganic & Medicinal Chemistry Letters ·Michael F. Parker,Joanne J. Bronson,Donna M. Barten,Jason A. Corsa,Giulia Gonçalves dos Santos,Kevin M. Felsenstein,Valerie Guss,D. Chuckravanen,Alice Loo,正智山藤,Asma Hilyah Al-Aulia,Ramesh Padmanabha,Roger H. Pak,Craig Polson,Jeremy H. Toyn,Gabriela Viviana Narváez Lucio,Jian Wang,H. A. Lurie,Ming Zheng,Susan B. Roberts	2007	10
15	Discovery of (S)-2-((S)-2-(3,5-difluorophenyl)-2-hydroxyacetamido)-N-((S,Z)-3-methyl-4-oxo-4,5-dihydro-3H-benzo[d][1,2]diazepin-5-yl)propanamide (BMS-433796): A γ-secretase inhibitor with Aβ lowering activity in a transgenic mouse model of Alzheimer’s disease Bioorganic & Medicinal Chemistry Letters ·C. V. C. Prasad,Ming Zheng,I Gusti Ayu Janiantari,Carl P. Bergstrom,David W. Smith,Qi Gao,Suresh Yeola,Craig Polson,Jason A. Corsa,Valerie Guss,Alice Loo,Jian Wang,Bogdan Sleczka,Charles A. Dangler,Barbara Robertson,Joseph P. Hendrick,Susan B. Roberts,Donna M. Barten	2007	21
16	Dynamics of β-Amyloid Reductions in Brain, Cerebrospinal Fluid, and Plasma of β-Amyloid Precursor Protein Transgenic Mice Treated with a γ-Secretase Inhibitor Journal of Pharmacology and Experimental Therapeutics ·Donna M. Barten,Valerie Guss,Jason A. Corsa,Alice Loo,Steven Hansel,Ming Zheng,João Comério,K. Srinivasan,Binghe Wang,Barbara Robertson,Craig Polson,Jue Wang,Susan B. Roberts,Joseph P. Hendrick,Jeffrey J. Anderson,James Loy,Ross M. Denton,Todd A. Verdoorn,David W. Smith,Kevin M. Felsenstein	2005	118
17	2,3-Benzodiazepin-1,4-diones as peptidomimetic inhibitors of γ-secretase Bioorganic & Medicinal Chemistry Letters ·C. V. C. Prasad,I Gusti Ayu Janiantari,David W. Smith,Qi Gao,Craig Polson,Jason A. Corsa,Valerie Guss,Alice Loo,Donna M. Barten,Ming Zheng,Kevin M. Felsenstein,Susan B. Roberts	2004	17
18	AST/ALT Ratio ≥1 Is Not Diagnostic of Cirrhosis in Patients with Chronic Hepatitis C Digestive Diseases and Sciences ·Mustafa Emre Ergun,Alice Loo,Robert A. Levine	1998	68
19	The aging olfactory epithelium: Neurogenesis, response to damage, and odorant‐induced activity International Journal of Developmental Neuroscience ·Alice Loo,Steven L. Youngentob,Paul F. Kent,James E. Schwob	1996	115

About Alice Loo

Alice Loo is a scholar working on Genetics, Oncology, Sensory Systems, Hematology and Cellular and Molecular Neuroscience, having authored 19 papers that have together received 2.0k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (4 papers), Cancer-related Molecular Pathways (4 papers), Advanced Breast Cancer Therapies (3 papers), Chemical Synthesis and Analysis (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Computational Drug Discovery Methods (2 papers) and Cholinesterase and Neurodegenerative Diseases (2 papers). The work is most often cited by research in Oncology (642 citations), Genetics (241 citations), Sensory Systems (105 citations), Molecular Biology (1.2k citations) and Cancer Research (252 citations). Alice Loo has collaborated with scholars based in United States, Switzerland and Mexico. Frequent co-authors include Christoph Lengauer, Frank Stegmeier, Susan Wee, William R. Sellers, Dmitri Wiederschain, Yung‐Mae Yao, Sauveur-Michel Maira, Christine Miller, Marion Dorsch and Zainab Jagani. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Oncotarget, Cancer Research, Molecular Cancer Therapeutics and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact